3 Potential New Molecules for Amyris’ Portfolio in 2014

Synthetic biology pioneer Amyris may have spent much of last year slashing wasteful spending and reevaluating its strategic vision, but it also achieved several major farnesene production milestones at its lone commercial facility in Brotas, Brazil. While the company will continue to [...]